{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:59:10Z","timestamp":1793498350824,"version":"4.5.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["31260134"],"award-info":[{"award-number":["31260134"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Tuberculosis (TB) kills more individuals in the world than any other disease, and a threat made direr by the coverage of drug-resistant strains of <jats:italic>Mycobacterium tuberculosis<\/jats:italic> (Mtb). Bacillus Calmette\u2013Gu\u00e9rin (BCG) is the single TB vaccine licensed for use in human beings and effectively protects infants and children against severe military and meningeal TB. We applied advanced computational techniques to develop a universal TB vaccine. In the current study, we select the very conserved, experimentally confirmed Mtb antigens, including Rv2608, Rv2684, Rv3804c (Ag85A), and Rv0125 (Mtb32A) to design a novel multi-epitope subunit vaccine. By using the Immune Epitopes Database (IEDB), we predicted different B-cell and T-cell epitopes. An adjuvant (Griselimycin) was also added to vaccine construct to improve its immunogenicity. Bioinformatics tools were used to predict, refined, and validate the 3D structure and then docked with toll-like-receptor (TLR-3) using different servers. The constructed vaccine was used for further processing based on allergenicity, antigenicity, solubility, different physiochemical properties, and molecular docking scores. The in silico immune simulation results showed significant response for immune cells. For successful expression of the vaccine in <jats:italic>E. coli<\/jats:italic>, in-silico cloning and codon optimization were performed. This research also sets out a good signal for the design of a peptide-based tuberculosis vaccine. In conclusion, our findings show that the known multi-epitope vaccine may activate humoral and cellular immune responses and maybe a possible tuberculosis vaccine candidate. Therefore, more experimental validations should be exposed to it.<\/jats:p>","DOI":"10.1038\/s41598-020-80899-6","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T11:15:21Z","timestamp":1610536521000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":213,"title":["In silico analysis of epitope-based vaccine candidate against tuberculosis using reverse vaccinology"],"prefix":"10.1038","volume":"11","author":[{"given":"Shaheen","family":"Bibi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inayat","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingdong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Adnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romana","family":"Liaqat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Bao","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiquan","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,13]]},"reference":[{"key":"80899_CR1","doi-asserted-by":"publisher","first-page":"5829","DOI":"10.1038\/ncomms6829","volume":"6","author":"KJ Minch","year":"2015","unstructured":"Minch, K. J. et al. The DNA-binding network of Mycobacterium tuberculosis. Nat. Commun. 6, 5829 (2015).","journal-title":"Nat. Commun."},{"key":"80899_CR2","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/1462-2920.14015","volume":"20","author":"A Maji","year":"2018","unstructured":"Maji, A. et al. Gut microbiome contributes to impairment of immunity in pulmonary tuberculosis patients by alteration of butyrate and propionate producers. Environ. Microbiol. 20, 402\u2013419 (2018).","journal-title":"Environ. Microbiol."},{"key":"80899_CR3","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1016\/S1473-3099(18)30537-1","volume":"19","author":"PY Khan","year":"2019","unstructured":"Khan, P. Y. et al. Transmission of drug-resistant tuberculosis in HIV-endemic settings. Lancet. Infect. Dis 19, e77\u2013e88 (2019).","journal-title":"Lancet. Infect. Dis"},{"key":"80899_CR4","first-page":"1","volume":"20","author":"N Singhvi","year":"2020","unstructured":"Singhvi, N. et al. Interplay of human gut microbiome in health and wellness. Indian J. Microbiol. 20, 1\u201311 (2020).","journal-title":"Indian J. Microbiol."},{"key":"80899_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-41008-4","volume":"9","author":"SA Prabowo","year":"2019","unstructured":"Prabowo, S. A. et al. Historical BCG vaccination combined with drug treatment enhances inhibition of mycobacterial growth ex vivo in human peripheral blood cells. Sci. Rep. 9, 1\u201312 (2019).","journal-title":"Sci. Rep."},{"key":"80899_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3389\/fimmu.2019.00113","volume":"10","author":"M Dalsass","year":"2019","unstructured":"Dalsass, M., Brozzi, A., Medini, D. & Rappuoli, R. Comparison of open-source reverse vaccinology programs for bacterial vaccine antigen discovery. Front. Immunol. 10, 113 (2019).","journal-title":"Front. Immunol."},{"key":"80899_CR7","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/sji.12465","volume":"84","author":"P M\u00e9ndez-Samperio","year":"2016","unstructured":"M\u00e9ndez-Samperio, P. Global efforts in the development of vaccines for tuberculosis: Requirements for improved vaccines against Mycobacterium tuberculosis. Scand. J. Immunol. 84, 204\u2013210 (2016).","journal-title":"Scand. J. Immunol."},{"key":"80899_CR8","unstructured":"M\u00e9ndez-Samperio, P. (Future Medicine, 2016)."},{"key":"80899_CR9","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1080\/14712598.2017.1378641","volume":"17","author":"R Zenteno-Cuevas","year":"2017","unstructured":"Zenteno-Cuevas, R. Successes and failures in human tuberculosis vaccine development. Expert Opin. Biol. Ther. 17, 1481\u20131491 (2017).","journal-title":"Expert Opin. Biol. Ther."},{"key":"80899_CR10","doi-asserted-by":"publisher","first-page":"945","DOI":"10.2217\/imt.15.60","volume":"7","author":"P Bali","year":"2015","unstructured":"Bali, P., Tousif, S., Das, G. & Van Kaer, L. Strategies to improve BCG vaccine efficacy. Immunotherapy 7, 945\u2013948 (2015).","journal-title":"Immunotherapy"},{"key":"80899_CR11","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1517\/14712598.2012.721768","volume":"12","author":"M Romano","year":"2012","unstructured":"Romano, M. & Huygen, K. An update on vaccines for tuberculosis\u2014there is more to it than just waning of BCG efficacy with time. Expert Opin. Biol. Ther. 12, 1601\u20131610 (2012).","journal-title":"Expert Opin. Biol. Ther."},{"key":"80899_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1475-2859-5-23","volume":"5","author":"A Detmer","year":"2006","unstructured":"Detmer, A. & Glenting, J. Live bacterial vaccines\u2014a review and identification of potential hazards. Microb. Cell Fact. 5, 23 (2006).","journal-title":"Microb. Cell Fact."},{"key":"80899_CR13","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1016\/j.vaccine.2016.02.079","volume":"34","author":"TG Evans","year":"2016","unstructured":"Evans, T. G., Schrager, L. & Thole, J. Status of vaccine research and development of vaccines for tuberculosis. Vaccine 34, 2911\u20132914 (2016).","journal-title":"Vaccine"},{"key":"80899_CR14","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1136\/thoraxjnl-2014-205202","volume":"70","author":"MEM Wilkie","year":"2015","unstructured":"Wilkie, M. E. M. & McShane, H. TB vaccine development: Where are we and why is it so difficult?. Thorax 70, 299\u2013301 (2015).","journal-title":"Thorax"},{"key":"80899_CR15","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.tube.2016.07.005","volume":"100","author":"P Gillard","year":"2016","unstructured":"Gillard, P. et al. Safety and immunogenicity of the M72\/AS01E candidate tuberculosis vaccine in adults with tuberculosis: A phase II randomised study. Tuberculosis 100, 118\u2013127 (2016).","journal-title":"Tuberculosis"},{"key":"80899_CR16","doi-asserted-by":"publisher","first-page":"5908","DOI":"10.1016\/j.vaccine.2014.09.001","volume":"32","author":"BMN Kagina","year":"2014","unstructured":"Kagina, B. M. N. et al. The novel tuberculosis vaccine, AERAS-402, is safe in healthy infants previously vaccinated with BCG, and induces dose-dependent CD4 and CD8T cell responses. Vaccine 32, 5908\u20135917 (2014).","journal-title":"Vaccine"},{"key":"80899_CR17","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3390\/vaccines2030515","volume":"2","author":"W Li","year":"2014","unstructured":"Li, W., Joshi, M. D., Singhania, S., Ramsey, K. H. & Murthy, A. K. Peptide vaccine: Progress and challenges. Vaccines 2, 515\u2013536 (2014).","journal-title":"Vaccines"},{"key":"80899_CR18","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/PPO.0b013e318233e5b2","volume":"17","author":"CL Slingluff Jr","year":"2011","unstructured":"Slingluff, C. L. Jr. The present and future of peptide vaccines for cancer: Single or multiple, long or short, alone or in combination?. Cancer J. (Sudbury Mass.) 17, 343 (2011).","journal-title":"Cancer J. (Sudbury Mass.)"},{"key":"80899_CR19","doi-asserted-by":"publisher","first-page":"104186","DOI":"10.1016\/j.meegid.2020.104186","volume":"80","author":"E Ong","year":"2020","unstructured":"Ong, E., He, Y. & Yang, Z. Epitope promiscuity and population coverage of Mycobacterium tuberculosis protein antigens in current subunit vaccines under development. Infect. Genet. Evol. 80, 104186 (2020).","journal-title":"Infect. Genet. Evol."},{"key":"80899_CR20","doi-asserted-by":"publisher","first-page":"e1005760","DOI":"10.1371\/journal.ppat.1005760","volume":"12","author":"CS Lindestam Arlehamn","year":"2016","unstructured":"Lindestam Arlehamn, C. S. et al. A quantitative analysis of complexity of human pathogen-specific CD4 T cell responses in healthy M. tuberculosis infected South Africans. PLoS Pathog. 12, e1005760 (2016).","journal-title":"PLoS Pathog."},{"key":"80899_CR21","doi-asserted-by":"publisher","first-page":"e1007643","DOI":"10.1371\/journal.ppat.1007643","volume":"15","author":"MJ Rodo","year":"2019","unstructured":"Rodo, M. J. et al. A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates. PLoS Pathog. 15, e1007643 (2019).","journal-title":"PLoS Pathog."},{"key":"80899_CR22","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.1016\/j.vaccine.2015.06.051","volume":"33","author":"AKK Luabeya","year":"2015","unstructured":"Luabeya, A. K. K. et al. First-in-human trial of the post-exposure tuberculosis vaccine H56: IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults. Vaccine 33, 4130\u20134140 (2015).","journal-title":"Vaccine"},{"key":"80899_CR23","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S2213-2600(18)30077-8","volume":"6","author":"A Penn-Nicholson","year":"2018","unstructured":"Penn-Nicholson, A. et al. Safety and immunogenicity of the novel tuberculosis vaccine ID93+ GLA-SE in BCG-vaccinated healthy adults in South Africa: A randomised, double-blind, placebo-controlled phase 1 trial. Lancet Respir. Med. 6, 287\u2013298 (2018).","journal-title":"Lancet Respir. Med."},{"key":"80899_CR24","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1164\/rccm.201802-0366OC","volume":"199","author":"S Suliman","year":"2019","unstructured":"Suliman, S. et al. Dose optimization of H56: IC31 vaccine for tuberculosis-endemic populations. A double-blind, placebo-controlled, dose-selection trial. Am. J. Respir. Crit. Care Med. 199, 220\u2013231 (2019).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"80899_CR25","doi-asserted-by":"crossref","unstructured":"Kumar, V. & Jena, M. Reverse vaccinology approach towards the in-silico multiepitope vaccine development against SARS-CoV-2. (2020).","DOI":"10.21203\/rs.3.rs-31779\/v1"},{"key":"80899_CR26","doi-asserted-by":"publisher","first-page":"e9572","DOI":"10.7717\/peerj.9572","volume":"8","author":"MS Rahman","year":"2020","unstructured":"Rahman, M. S. et al. Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2 etiologic agent of global pandemic COVID-19: An in silico approach. PeerJ 8, e9572 (2020).","journal-title":"PeerJ"},{"key":"80899_CR27","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3390\/vaccines8030423","volume":"8","author":"N Rahman","year":"2020","unstructured":"Rahman, N. et al. Vaccine design from the ensemble of surface glycoprotein epitopes of SARS-CoV-2: An immunoinformatics approach. Vaccines 8, 423 (2020).","journal-title":"Vaccines"},{"key":"80899_CR28","doi-asserted-by":"publisher","first-page":"151949","DOI":"10.1016\/j.imbio.2020.151949","volume":"20","author":"A Ullah","year":"2020","unstructured":"Ullah, A., Sarkar, B. & Islam, S. S. Exploiting the reverse vaccinology approach to design novel subunit vaccine against ebola virus. Immunobiology 20, 151949 (2020).","journal-title":"Immunobiology"},{"key":"80899_CR29","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jmgm.2017.10.004","volume":"78","author":"SA Damfo","year":"2017","unstructured":"Damfo, S. A., Reche, P., Gatherer, D. & Flower, D. R. In silico design of knowledge-based Plasmodium falciparum epitope ensemble vaccines. J. Mol. Graph. Model. 78, 195\u2013205 (2017).","journal-title":"J. Mol. Graph. Model."},{"key":"80899_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-26689-7","volume":"8","author":"V Solanki","year":"2018","unstructured":"Solanki, V. & Tiwari, V. Subtractive proteomics to identify novel drug targets and reverse vaccinology for the development of chimeric vaccine against Acinetobacter baumannii. Sci. Rep. 8, 1\u201319 (2018).","journal-title":"Sci. Rep."},{"key":"80899_CR31","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.molimm.2019.05.016","volume":"114","author":"K Ahmadi","year":"2019","unstructured":"Ahmadi, K. et al. Epitope-based immunoinformatics study of a novel Hla-MntC-SACOL0723 fusion protein from Staphylococcus aureus: Induction of multi-pattern immune responses. Mol. Immunol. 114, 88\u201399 (2019).","journal-title":"Mol. Immunol."},{"key":"80899_CR32","doi-asserted-by":"publisher","first-page":"107209","DOI":"10.1016\/j.compbiolchem.2020.107209","volume":"85","author":"Z Yazdani","year":"2020","unstructured":"Yazdani, Z. et al. Designing a potent L1 protein-based HPV peptide vaccine: A bioinformatics approach. Comput. Biol. Chem. 85, 107209 (2020).","journal-title":"Comput. Biol. Chem."},{"key":"80899_CR33","doi-asserted-by":"publisher","first-page":"848","DOI":"10.3390\/pharmaceutics12090848","volume":"12","author":"J Watt","year":"2020","unstructured":"Watt, J. & Liu, J. Preclinical progress of subunit and live attenuated Mycobacterium tuberculosis vaccines: A review following the first in human efficacy trial. Pharmaceutics 12, 848 (2020).","journal-title":"Pharmaceutics"},{"key":"80899_CR34","doi-asserted-by":"publisher","first-page":"baz113","DOI":"10.1093\/database\/baz113","volume":"2019","author":"MJ Skwark","year":"2019","unstructured":"Skwark, M. J. et al. Mabellini: A genome-wide database for understanding the structural proteome and evaluating prospective antimicrobial targets of the emerging pathogen Mycobacterium abscessus. Database 2019, baz113 (2019).","journal-title":"Database"},{"key":"80899_CR35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.tube.2010.09.006","volume":"91","author":"A Kapopoulou","year":"2011","unstructured":"Kapopoulou, A., Lew, J. M. & Cole, S. T. The MycoBrowser portal: A comprehensive and manually annotated resource for mycobacterial genomes. Tuberculosis 91, 8\u201313 (2011).","journal-title":"Tuberculosis"},{"key":"80899_CR36","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1186\/1471-2105-8-424","volume":"8","author":"MV Larsen","year":"2007","unstructured":"Larsen, M. V. et al. Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction. BMC Bioinform. 8, 424 (2007).","journal-title":"BMC Bioinform."},{"key":"80899_CR37","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.4049\/jimmunol.171.4.1741","volume":"171","author":"B Peters","year":"2003","unstructured":"Peters, B., Bulik, S., Tampe, R., Van Endert, P. M. & Holzh\u00fctter, H.-G. Identifying MHC class I epitopes by predicting the TAP transport efficiency of epitope precursors. J. Immunol. 171, 1741\u20131749 (2003).","journal-title":"J. Immunol."},{"key":"80899_CR38","doi-asserted-by":"publisher","first-page":"W513","DOI":"10.1093\/nar\/gkn254","volume":"36","author":"Q Zhang","year":"2008","unstructured":"Zhang, Q. et al. Immune epitope database analysis resource (IEDB-AR). Nucleic Acids Res. 36, W513\u2013W518 (2008).","journal-title":"Nucleic Acids Res."},{"key":"80899_CR39","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1745-6150-8-30","volume":"8","author":"SK Dhanda","year":"2013","unstructured":"Dhanda, S. K., Vir, P. & Raghava, G. P. S. Designing of interferon-gamma inducing MHC class-II binders. Biol. Direct 8, 30 (2013).","journal-title":"Biol. Direct"},{"key":"80899_CR40","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/prot.21078","volume":"65","author":"S Saha","year":"2006","unstructured":"Saha, S. & Raghava, G. P. S. Prediction of continuous B-cell epitopes in an antigen using recurrent neural network. Prot. Struct. Funct. Bioinform. 65, 40\u201348 (2006).","journal-title":"Prot. Struct. Funct. Bioinform."},{"key":"80899_CR41","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1093\/bioinformatics\/btq551","volume":"26","author":"CN Magnan","year":"2010","unstructured":"Magnan, C. N. et al. High-throughput prediction of protein antigenicity using protein microarray data. Bioinformatics 26, 2936\u20132943 (2010).","journal-title":"Bioinformatics"},{"key":"80899_CR42","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2105-8-4","volume":"8","author":"IA Doytchinova","year":"2007","unstructured":"Doytchinova, I. A. & Flower, D. R. VaxiJen: A server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinform. 8, 4 (2007).","journal-title":"BMC Bioinform."},{"key":"80899_CR43","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1016\/j.vaccine.2018.03.042","volume":"36","author":"RK Pandey","year":"2018","unstructured":"Pandey, R. K., Ojha, R., Aathmanathan, V. S., Krishnan, M. & Prajapati, V. K. Immunoinformatics approaches to design a novel multi-epitope subunit vaccine against HIV infection. Vaccine 36, 2262\u20132272 (2018).","journal-title":"Vaccine"},{"key":"80899_CR44","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1007\/s00894-014-2278-5","volume":"20","author":"I Dimitrov","year":"2014","unstructured":"Dimitrov, I., Bangov, I., Flower, D. R. & Doytchinova, I. AllerTOP v.2\u2014a server for in silico prediction of allergens. J. Mol. Model. 20, 2278 (2014).","journal-title":"J. Mol. Model."},{"key":"80899_CR45","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1093\/bioinformatics\/btt619","volume":"30","author":"I Dimitrov","year":"2014","unstructured":"Dimitrov, I., Naneva, L., Doytchinova, I. & Bangov, I. AllergenFP: Allergenicity prediction by descriptor fingerprints. Bioinformatics 30, 846\u2013851 (2014).","journal-title":"Bioinformatics"},{"key":"80899_CR46","doi-asserted-by":"publisher","first-page":"104199","DOI":"10.1016\/j.meegid.2020.104199","volume":"80","author":"F Shahid","year":"2020","unstructured":"Shahid, F., Ashfaq, U. A., Javaid, A. & Khalid, H. Immunoinformatics guided rational design of a next generation multi epitope based peptide (MEBP) vaccine by exploring Zika virus proteome. Infect. Genet. Evol. 80, 104199 (2020).","journal-title":"Infect. Genet. Evol."},{"key":"80899_CR47","doi-asserted-by":"publisher","first-page":"e73957","DOI":"10.1371\/journal.pone.0073957","volume":"8","author":"S Gupta","year":"2013","unstructured":"Gupta, S. et al. In silico approach for predicting toxicity of peptides and proteins. PLoS\u00a0One 8, e73957 (2013).","journal-title":"PLoS\u00a0One"},{"key":"80899_CR48","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1126\/science.aaa4690","volume":"348","author":"A Kling","year":"2015","unstructured":"Kling, A. et al. Targeting DnaN for tuberculosis therapy using novel griselimycins. Science 348, 1106\u20131112 (2015).","journal-title":"Science"},{"key":"80899_CR49","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1385\/1-59259-890-0:571","volume-title":"The Proteomics Protocols Handbook","author":"E Gasteiger","year":"2005","unstructured":"Gasteiger, E. et al. The Proteomics Protocols Handbook 571\u2013607 (Springer, Berlin, 2005)."},{"key":"80899_CR50","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1093\/bioinformatics\/btx345","volume":"33","author":"M Hebditch","year":"2017","unstructured":"Hebditch, M., Carballo-Amador, M. A., Charonis, S., Curtis, R. & Warwicker, J. Protein\u2013Sol: A web tool for predicting protein solubility from sequence. Bioinformatics 33, 3098\u20133100 (2017).","journal-title":"Bioinformatics"},{"key":"80899_CR51","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/bioinformatics\/16.4.404","volume":"16","author":"LJ McGuffin","year":"2000","unstructured":"McGuffin, L. J., Bryson, K. & Jones, D. T. The PSIPRED protein structure prediction server. Bioinformatics 16, 404\u2013405 (2000).","journal-title":"Bioinformatics"},{"key":"80899_CR52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"S Wang","year":"2016","unstructured":"Wang, S., Peng, J., Ma, J. & Xu, J. Protein secondary structure prediction using deep convolutional neural fields. Sci. Rep. 6, 1\u201311 (2016).","journal-title":"Sci. Rep."},{"key":"80899_CR53","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nmeth.3213","volume":"12","author":"J Yang","year":"2015","unstructured":"Yang, J. et al. The I-TASSER Suite: Protein structure and function prediction. Nat. Methods 12, 7\u20138 (2015).","journal-title":"Nat. Methods"},{"key":"80899_CR54","first-page":"1020","volume":"68","author":"Y Zhang","year":"2007","unstructured":"Zhang, Y. & Skolnick, J. Scoring function for automated assessment of protein structure template quality. Prot. N. Y. 68, 1020 (2007).","journal-title":"Prot. N. Y."},{"key":"80899_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-40833-x","volume":"9","author":"RA Shey","year":"2019","unstructured":"Shey, R. A. et al. In-silico design of a multi-epitope vaccine candidate against onchocerciasis and related filarial diseases. Sci. Rep. 9, 1\u201318 (2019).","journal-title":"Sci. Rep."},{"key":"80899_CR56","doi-asserted-by":"publisher","first-page":"W384","DOI":"10.1093\/nar\/gkt458","volume":"41","author":"L Heo","year":"2013","unstructured":"Heo, L., Park, H. & Seok, C. GalaxyRefine: Protein structure refinement driven by side-chain repacking. Nucleic Acids Res. 41, W384\u2013W388 (2013).","journal-title":"Nucleic Acids Res."},{"key":"80899_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-08842-w","volume":"7","author":"N Khatoon","year":"2017","unstructured":"Khatoon, N., Pandey, R. K. & Prajapati, V. K. Exploring Leishmania secretory proteins to design B and T cell multi-epitope subunit vaccine using immunoinformatics approach. Sci. Rep. 7, 1\u201312 (2017).","journal-title":"Sci. Rep."},{"key":"80899_CR58","doi-asserted-by":"publisher","first-page":"W407","DOI":"10.1093\/nar\/gkm290","volume":"35","author":"M Wiederstein","year":"2007","unstructured":"Wiederstein, M. & Sippl, M. J. ProSA-web: Interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res. 35, W407\u2013W410 (2007).","journal-title":"Nucleic Acids Res."},{"key":"80899_CR59","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/prot.10286","volume":"50","author":"SC Lovell","year":"2003","unstructured":"Lovell, S. C. et al. Structure validation by C\u03b1 geometry: \u03d5, \u03c8 and C\u03b2 deviation. Prot. Struct. Funct. Bioinform. 50, 437\u2013450 (2003).","journal-title":"Prot. Struct. Funct. Bioinform."},{"key":"80899_CR60","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s10989-018-9734-5","volume":"25","author":"S Bhati","year":"2019","unstructured":"Bhati, S., Kaushik, V. & Singh, J. In silico identification of piperazine linked thiohydantoin derivatives as novel androgen antagonist in prostate cancer treatment. Int. J. Pept. Res. Ther. 25, 845\u2013860 (2019).","journal-title":"Int. J. Pept. Res. Ther."},{"key":"80899_CR61","doi-asserted-by":"publisher","first-page":"W322","DOI":"10.1093\/nar\/gkz397","volume":"47","author":"G Weng","year":"2019","unstructured":"Weng, G. et al. HawkDock: A web server to predict and analyze the protein\u2013protein complex based on computational docking and MM\/GBSA. Nucleic Acids Res. 47, W322\u2013W330 (2019).","journal-title":"Nucleic Acids Res."},{"key":"80899_CR62","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1093\/bioinformatics\/btr497","volume":"27","author":"JR Lop\u00e9z-Blanco","year":"2011","unstructured":"Lop\u00e9z-Blanco, J. R., Garz\u00f3n, J. I. & Chac\u00f3n, P. iMod: Multipurpose normal mode analysis in internal coordinates. Bioinformatics 27, 2843\u20132850 (2011).","journal-title":"Bioinformatics"},{"key":"80899_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-09199-w","volume":"7","author":"M Ali","year":"2017","unstructured":"Ali, M. et al. Exploring dengue genome to construct a multi-epitope based subunit vaccine by utilizing immunoinformatics approach to battle against dengue infection. Sci. Rep. 7, 1\u201313 (2017).","journal-title":"Sci. Rep."},{"key":"80899_CR64","first-page":"20","volume":"1","author":"KA Peele","year":"2020","unstructured":"Peele, K. A., Srihansa, T., Krupanidhi, S., Sai, A. V. & Venkateswarulu, T. Design of multi-epitope vaccine candidate against SARS-CoV-2: A in-silico study. J. Biomol. Struct. Dyn. 1, 20 (2020).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"80899_CR65","first-page":"1895","volume":"88","author":"A Ikai","year":"1980","unstructured":"Ikai, A. Thermostability and aliphatic index of globular proteins. J. Biochem. 88, 1895\u20131898 (1980).","journal-title":"J. Biochem."},{"key":"80899_CR66","doi-asserted-by":"publisher","first-page":"934","DOI":"10.3389\/fimmu.2019.00934","volume":"10","author":"A Riccomi","year":"2019","unstructured":"Riccomi, A. et al. Parenteral vaccination with a tuberculosis subunit vaccine in presence of retinoic acid provides early but transient protection to M. tuberculosis infection. Front. Immunol. 10, 934 (2019).","journal-title":"Front. Immunol."},{"key":"80899_CR67","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.2174\/1381612823666170913163904","volume":"24","author":"K Reginald","year":"2018","unstructured":"Reginald, K., Chan, Y., Plebanski, M. & Poh, C. L. Development of peptide vaccines in dengue. Curr. Pharm. Des. 24, 1157\u20131173 (2018).","journal-title":"Curr. Pharm. Des."},{"key":"80899_CR68","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/08830185.2019.1657426","volume":"38","author":"AA Bahrami","year":"2019","unstructured":"Bahrami, A. A., Payandeh, Z., Khalili, S., Zakeri, A. & Bandehpour, M. Immunoinformatics: In silico approaches and computational design of a multi-epitope, immunogenic protein. Int. Rev. Immunol. 38, 307\u2013322 (2019).","journal-title":"Int. Rev. Immunol."},{"key":"80899_CR69","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nri.2016.107","volume":"17","author":"L Galluzzi","year":"2017","unstructured":"Galluzzi, L., Buqu\u00e9, A., Kepp, O., Zitvogel, L. & Kroemer, G. Immunogenic cell death in cancer and infectious disease. Nat. Rev. Immunol. 17, 97 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"80899_CR70","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/bfgp\/ely020","volume":"17","author":"KK Dubey","year":"2018","unstructured":"Dubey, K. K. et al. Vaccine and antibody production in plants: Developments and computational tools. Brief. Funct. Genom. 17, 295\u2013307 (2018).","journal-title":"Brief. Funct. Genom."},{"key":"80899_CR71","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nri.2017.106","volume":"18","author":"LL Lu","year":"2018","unstructured":"Lu, L. L., Suscovich, T. J., Fortune, S. M. & Alter, G. Beyond binding: Antibody effector functions in infectious diseases. Nat. Rev. Immunol. 18, 46 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"80899_CR72","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/jmr.893","volume":"21","author":"Y El-Manzalawy","year":"2008","unstructured":"El-Manzalawy, Y., Dobbs, D. & Honavar, V. Predicting linear B-cell epitopes using string kernels. J. Mol. Recogn. Interdiscip. J. 21, 243\u2013255 (2008).","journal-title":"J. Mol. Recogn. Interdiscip. J."},{"key":"80899_CR73","doi-asserted-by":"publisher","first-page":"103937","DOI":"10.1016\/j.micpath.2019.103937","volume":"140","author":"Z Krocova","year":"2020","unstructured":"Krocova, Z. et al. The role of B cells in an early immune response to Mycobacterium bovis. Microb. Pathog. 140, 103937 (2020).","journal-title":"Microb. Pathog."},{"key":"80899_CR74","first-page":"104357","volume":"20","author":"S Verma","year":"2020","unstructured":"Verma, S., Singhvi, N., Singh, Y. & Shukla, P. Computational approaches in epitope design using DNA binding proteins as vaccine candidate in Mycobacterium tuberculosis. Infect. Genet. Evol. 20, 104357 (2020).","journal-title":"Infect. Genet. Evol."},{"key":"80899_CR75","doi-asserted-by":"publisher","first-page":"5371","DOI":"10.1016\/j.vaccine.2019.07.033","volume":"37","author":"CS Eickhoff","year":"2019","unstructured":"Eickhoff, C. S. et al. Highly conserved influenza T cell epitopes induce broadly protective immunity. Vaccine 37, 5371\u20135381 (2019).","journal-title":"Vaccine"},{"key":"80899_CR76","first-page":"1","volume":"20","author":"YR Patankar","year":"2019","unstructured":"Patankar, Y. R. et al. Limited recognition of Mycobacterium tuberculosis-infected macrophages by polyclonal CD4 and CD8 T cells from the lungs of infected mice. Mucosal Immunol. 20, 1\u20139 (2019).","journal-title":"Mucosal Immunol."},{"key":"80899_CR77","doi-asserted-by":"publisher","first-page":"3564","DOI":"10.1016\/j.celrep.2019.11.034","volume":"29","author":"SL Russell","year":"2019","unstructured":"Russell, S. L. et al. Compromised metabolic reprogramming is an early indicator of CD8+ T cell dysfunction during chronic Mycobacterium tuberculosis infection. Cell Rep. 29, 3564\u20133579 (2019).","journal-title":"Cell Rep."},{"key":"80899_CR78","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.meegid.2017.02.007","volume":"49","author":"B Meza","year":"2017","unstructured":"Meza, B., Ascencio, F., Sierra-Beltr\u00e1n, A. P., Torres, J. & Angulo, C. A novel design of a multi-antigenic, multistage and multi-epitope vaccine against Helicobacter pylori: An in silico approach. Infect. Genet. Evol. 49, 309\u2013317 (2017).","journal-title":"Infect. Genet. Evol."},{"key":"80899_CR79","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/protein\/14.8.529","volume":"14","author":"R Arai","year":"2001","unstructured":"Arai, R., Ueda, H., Kitayama, A., Kamiya, N. & Nagamune, T. Design of the linkers which effectively separate domains of a bifunctional fusion protein. Protein Eng. 14, 529\u2013532 (2001).","journal-title":"Protein Eng."},{"key":"80899_CR80","doi-asserted-by":"publisher","first-page":"e1005667","DOI":"10.1371\/journal.ppat.1005667","volume":"12","author":"S Sakai","year":"2016","unstructured":"Sakai, S. et al. CD4 T cell-derived IFN-\u03b3 plays a minimal role in control of pulmonary Mycobacterium tuberculosis infection and must be actively repressed by PD-1 to prevent lethal disease. PLoS Pathog. 12, e1005667 (2016).","journal-title":"PLoS Pathog."},{"key":"80899_CR81","first-page":"259","volume":"7","author":"G Corradin","year":"2007","unstructured":"Corradin, G., Villard, V. & Kajava, A. V. Protein structure based strategies for antigen discovery and vaccine development against malaria and other pathogens. Endocrine Metab. Immune Disord. Drug Targets (Formerly Curr. Drug Targets Immune Endocrine Metab, Disord.) 7, 259\u2013265 (2007).","journal-title":"Endocrine Metab. Immune Disord. Drug Targets (Formerly Curr. Drug Targets Immune Endocrine Metab, Disord.)"},{"key":"80899_CR82","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00726-013-1526-9","volume":"45","author":"A Gori","year":"2013","unstructured":"Gori, A., Longhi, R., Peri, C. & Colombo, G. Peptides for immunological purposes: Design, strategies and applications. Amino Acids 45, 257\u2013268 (2013).","journal-title":"Amino Acids"},{"key":"80899_CR83","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.biotechadv.2011.09.013","volume":"30","author":"R Chen","year":"2012","unstructured":"Chen, R. Bacterial expression systems for recombinant protein production: E. coli and beyond. Biotechnol. Adv. 30, 1102\u20131107 (2012).","journal-title":"Biotechnol. Adv."},{"key":"80899_CR84","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3389\/fmicb.2014.00172","volume":"5","author":"GL Rosano","year":"2014","unstructured":"Rosano, G. L. & Ceccarelli, E. A. Recombinant protein expression in Escherichia coli: Advances and challenges. Front. Microbiol. 5, 172 (2014).","journal-title":"Front. Microbiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80899-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80899-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80899-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T22:09:47Z","timestamp":1674857387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80899-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,13]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["80899"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-80899-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,13]]},"assertion":[{"value":"28 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1249"}}